These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21757444)

  • 1. Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging.
    Hipp SJ; Steffen-Smith E; Hammoud D; Shih JH; Bent R; Warren KE
    Neuro Oncol; 2011 Aug; 13(8):904-9. PubMed ID: 21757444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma.
    Steffen-Smith EA; Venzon DJ; Bent RS; Hipp SJ; Warren KE
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):774-9. PubMed ID: 22445531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma.
    Steffen-Smith EA; Shih JH; Hipp SJ; Bent R; Warren KE
    J Neurooncol; 2011 Nov; 105(2):365-73. PubMed ID: 21567301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies.
    Löbel U; Hwang S; Edwards A; Li Y; Li X; Broniscer A; Patay Z
    Neuroradiology; 2016 Oct; 58(10):1027-1034. PubMed ID: 27438806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study.
    Goda JS; Dutta D; Raut N; Juvekar SL; Purandare N; Rangarajan V; Arora B; Gupta T; Kurkure P; Jalali R
    Pediatr Neurosurg; 2013; 49(5):274-81. PubMed ID: 25277867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
    Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
    J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
    Matsusue E; Fink JR; Rockhill JK; Ogawa T; Maravilla KR
    Neuroradiology; 2010 Apr; 52(4):297-306. PubMed ID: 19834699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.
    Yamasaki F; Kurisu K; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Saito T; Hanaya R; Sugiyama K
    Neuro Oncol; 2011 Jul; 13(7):791-801. PubMed ID: 21653595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
    Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.
    Broniscer A; Gajjar A; Bhargava R; Langston JW; Heideman R; Jones D; Kun LE; Taylor J
    Neurosurgery; 1997 Feb; 40(2):331-7; discussion 337-8. PubMed ID: 9007866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of multimodal
    Morana G; Tortora D; Bottoni G; Puntoni M; Piatelli G; Garibotto F; Barra S; Giannelli F; Cistaro A; Severino M; Verrico A; Milanaccio C; Massimino M; Garrè ML; Rossi A; Piccardo A
    Theranostics; 2020; 10(26):11881-11891. PubMed ID: 33204317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of mitochondrial impairment in traumatic brain injury using high-resolution proton magnetic resonance spectroscopy.
    Signoretti S; Marmarou A; Aygok GA; Fatouros PP; Portella G; Bullock RM
    J Neurosurg; 2008 Jan; 108(1):42-52. PubMed ID: 18173309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurements of the pons as a biomarker of progression for pediatric DIPG.
    Steffen-Smith EA; Baker EH; Venzon D; Shandilya S; Bent RS; Warren KE
    J Neurooncol; 2014 Jan; 116(1):127-33. PubMed ID: 24113877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.